Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MTS-01 for Prevention of Radiation-Induced Alopecia
NCT00801086Phase 2Unknown
- Sponsor
- Mitos Pharmaceuticals, Inc.
- Start
- Nov 2008
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tempol in radiation-induced alopecia (RIA), sponsored by Mitos Pharmaceuticals, Inc.. Status: unknown.
02
Drugs
tempol
03
Conditions
radiation-induced alopecia (RIA)
Beyond the preview
Go deeper on NCT00801086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00801086.